Cargando…
Inhibition of insulin‐like growth factor 2 mRNA‐binding protein 1 sensitizes colorectal cancer cells to chemotherapeutics
Although colorectal cancer (CRC) treatment has seen a remarkable improvement in the recent years, many patients will develop metastasis due to the resistance of cancer cells to chemotherapeutics. Targeting mechanisms driving the resistance of CRC cells to treatment would significantly reduce cases o...
Autores principales: | Betson, Nicole, Hajahmed, Mohammed, Gebretsadek, Tsige, Ndebele, Kenneth, Ahmad, H. Anwar, Tchounwou, Paul B., Spiegelman, Vladimir S., Noubissi, Felicite K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721091/ https://www.ncbi.nlm.nih.gov/pubmed/36479210 http://dx.doi.org/10.1096/fba.2021-00069 |
Ejemplares similares
-
Cross-Talk between Wnt and Hh Signaling Pathways in the Pathology of Basal Cell Carcinoma
por: Noubissi, Felicite K., et al.
Publicado: (2018) -
Inhibition of the mRNA-Binding Protein IGF2BP1 Suppresses Proliferation and Sensitizes Neuroblastoma Cells to Chemotherapeutic Agents
por: Biegel, Jason M., et al.
Publicado: (2021) -
Advances in Our Understanding of the Molecular Mechanisms of Action of Cisplatin in Cancer Therapy
por: Tchounwou, Paul B, et al.
Publicado: (2021) -
Prostate Cancer Disparity, Chemoprevention, and Treatment by Specific Medicinal Plants
por: Yedjou, Clement G., et al.
Publicado: (2019) -
An In Vitro Inverted Vertical Invasion Assay to Avoid Manipulation of Rare or Sensitive Cell Types
por: McArdle, Tanner J., et al.
Publicado: (2016)